Molina AS, Orret CD, Pérez RA, Gutiérrez GF

Language: Spanish
References: 15
Page: 307-317
PDF size: 152.09 Kb.

ABSTRACT

Introduction: in the replacement therapy of end-stage renal disease, the previous creation of a permanent vascular access is required when hemodialysis is chosen as a depurative method. Autologous arteriovenous fistula is the most widely used angioaccess because of its advantages. The objective of the present study was to assess the demographic data of this population and their relationship with the annual survival of arteriovenous fistulae in this group.
Methods: a longitudinal prospective and descriptive study was conducted in 109 patients in whom 115 arteriovenous fistulae were created. They had been referred to the Department of Surgery of the Nephrology Institute of Havana in order to create vascular access for hemodialysis in the period from March 2005 through March 2007. The risk factors in the fistula survival were analyzed.
Results: males slightly predominated (59 males and 50 females). The average age was 52.5 years. Nephroangiosclerosis followed by diabetic nephropathy and polycystic kidney disease were the predominant causes of end-stage renal disease. Glomerular filtration average for these patients was 18.73 ml/min. Fifty nine had a previous vascular access. A lower survival or primary patency rate was found in diabetic patients and in cases of humerobasilic fistulae, without any statistically significant relation in this last aspect (p>0.05). Thirty five percent of the patients were under hemodialysis therapy at the time of arteriovenous fistula placement.
Conclusions: autologous arteriovenous fistula remains as a preferred vascular access due to its lower rate of complications. The selection of the correct placement site prior to the procedure is critical. Diabetes mellitus is an important risk factor which may have a significant effect on lower survival rates of vascular accesses.

REFERENCES

1. Dixon BS, Novak L, Fangman J. Hemodialysis vascular access survival: Upper arm native arteriovenous fistulas. Am J Kidney Dis. 2002;39:92-101.

2. Wong V, Ward R, Taylor J.Factors associated with early failure of arteriovenous fistula for hemodialysis access. Eur J Vasc Endovas Surg. 1996,12:207-13,

3. Donato M, Rovira P, Ramos J. Influencia del flujo sanguíneo sobre la supervivencia de las fístulas arteriovenosas en hemodiálisis. SEDEN 2005-2007

4. Rodríguez Hernández JA, López Pedreta J, Piera L. El acceso vascular en España: Análisis de su distribución, morbilidad y sistemas de monitorización. Nefrología. 2001;21(1):45-51.

5. Brittinger WD, Walker G, Twittenhoff WD, Konrad N. Vascular access for Hemodialysis in children. Pediatr Nephrol. 1997;11:87-95.

6. Termed-Rodriguez F, Mounton A. Salvage of immature forearm fistulas for hemodialysis by interventional radiology. Nephrol. Dial. And Transplant. 2002;16:2365-71.

7. Hirth RA, Turenne MN, Woods JD. Predictors of type of vascular access in hemodialysis patients. JAMA. 1996;276:1303-7.

8. Miller PE, Tolwani A, Luscy CP. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int. 1998;53:473-9.

9. Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney International. 2003;64:346-52 9.

10. Napan Navarro MM, Obando Castro R, García Cano MC. Comparación del comportamiento de las fístulas arteriovenosas en pacientes diabéticos. Octubre de 2001 a Febrero de 2002. Centro de Hemodiálisis. Es Salud, Lima, Perù. 3er Congreso de Nefrología por Internet; 2003.

11. Polo JR. Accesos vasculares para la hemodiálisis. En: F. LLach y F. Valderrábano. Insuficiencia Renal Crónica. Diálisis y Trasplante Renal. Madrid: Ediciones Norma; 1997. p. 927-52.

12. Tardois JH, Heneveled H, Elkelboon BC, Kitslaar PJ. The correlation between clinical and duplex ultrasound parameters and the development of complications in arteriovenous fistulas for hemodialysis. Eur J Vasc Surg. 1990;4:179-84.

13. Beathard GA, Sehte SM. Salvage of the nonfunctioning arteriovenous fistula. Am. J. Kidney Des. 1998;33:910-6.

14. NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 19997;37(Suppl 1):s150-s191.

15. Sheth RD, Brandt ML, Brewer ED. Permanent hemodialysis vascular access survival in children and adolescents with end-stage renal disease. Kidney Internationa. 2002;62():1864-9.